DeepMed Research

University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico

Not Applicable

Conditions: ADHD

Interventions: Behavioral: CLS-A-FUERTE

First Posted Date: 2024-06-13

Last Posted Date: 2025-04-08

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 872

Registration Number: NCT06457256

Locations: 🇲🇽
Benemérita Universidad Autónoma de Puebla, Puebla De Zaragoza, Puebla, Mexico
🇲🇽
Universidad Autonoma de Sinaloa, Culiacán, Sinaloa, Mexico
🇺🇸
UCSF, San Francisco, California, United States

Platelet Rich Plasma Injections In Young And Old Human Subjects

Phase 2

Not yet recruiting

Conditions: Musculoskeletal Disorders
Osteoarthritis
Articular Cartilage

Interventions: Drug: Platelet-Rich Plasma (PRP) Injections
Device: Centrifuge

First Posted Date: 2024-06-11

Last Posted Date: 2024-06-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 60

Registration Number: NCT06451120

Locations: 🇺🇸
University of California, San Francisco, California, United States

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Phase 3

Not yet recruiting

Conditions: Tuberculosis, MDR
Tuberculosis, Pulmonary
Tuberculosis, Multidrug-Resistant

Interventions: Drug: Control Arm FQ-S MDR/RR-TB regimen, designed according to latest WHO guidelines
Drug: Bedaquiline
Drug: Linezolid
Drug: Pretomanid
Drug: Moxifloxacin

First Posted Date: 2024-06-04

Last Posted Date: 2025-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 690

Registration Number: NCT06441006

Locations: 🇲🇩
Institute of Phthisiopneumology Chiril Dragniuc, Chisinau, Moldova, Republic of
🇲🇳
National Center for Communicable Diseases, Ulaanbaatar, Mongolia
🇵🇪
Hospital Nacional Hipólito Unanue, Lima, Peru

and more 7 locations

Levothyroxine Supplementation for Heart Transplant Recipients

Phase 1

Recruiting

Conditions: Heart Transplant Failure
Heart Transplant Infection

Interventions: Drug: Normal saline
Drug: Levothyroxine

First Posted Date: 2024-05-24

Last Posted Date: 2025-05-01

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 97

Registration Number: NCT06428097

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)

Not Applicable

Not yet recruiting

Conditions: ART Adherence

Interventions: Behavioral: POC urine assay informed enhanced ART adherence counselling for viral suppression

First Posted Date: 2024-05-21

Last Posted Date: 2024-12-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 500

Registration Number: NCT06423612

Locations: 🇿🇦
Desmond Tutu HIV Foundation, East London, South Africa

Randomized Directly Observed Therapy Study to Interpret Clinical Trials of Doxy-PEP

Early Phase 1

Recruiting

Conditions: Sexually Transmitted Diseases, Bacterial

Interventions: Drug: Doxycycline Pill

First Posted Date: 2024-05-16

Last Posted Date: 2025-03-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 48

Registration Number: NCT06414408

Locations: 🇺🇸
University of California, San Francisco/San Francisco General Hospital, San Francisco, California, United States

Transforming Health and Reducing Perinatal Anxiety Through Virtual Engagement

Not Applicable

Suspended

Conditions: Anxiety

Interventions: Behavioral: Digital CBT

First Posted Date: 2024-05-08

Last Posted Date: 2024-10-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 132

Registration Number: NCT06404450

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

Phase 2

Recruiting

Conditions: Seizures
Status Epilepticus
Heart Arrest

Interventions: Drug: Perampanel
Drug: Placebo

First Posted Date: 2024-05-07

Last Posted Date: 2024-06-20

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 52

Registration Number: NCT06401707

Locations: 🇺🇸
Zuckerberg San Francisco General Hospital, San Francisco, California, United States

Enhancing Attention and Wellbeing Using Digital Therapeutics

Not Applicable

Recruiting

Conditions: Aging
MCI
Cognitive Decline

Interventions: Device: MediTrain
Device: Worder

First Posted Date: 2024-05-03

Last Posted Date: 2024-10-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 4000

Registration Number: NCT06397469

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States

A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

Not Applicable

Recruiting

Conditions: Obesity, Childhood

Interventions: Behavioral: Futuros Fuertes 2.0
Behavioral: Control

First Posted Date: 2024-05-03

Last Posted Date: 2025-04-27

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 576

Registration Number: NCT06398509

Locations: 🇺🇸
Valley Health Center Sunnyvale, Sunnyvale, California, United States
🇺🇸
Children's Health Center San Francisco General Hospital, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy